Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Compare yields across Ex Us dividend ETFs to see which funds currently offer the highest income potential and sustainable payouts.
27,628 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A new move from Google signals a shift in AI compute. This could tilt the balance away from Nvidia in certain cloud a...
Pi Network faces another potential delay as it advances Protocol 25. The June 18 deadline could be missed, echoing pa...
A rare bipartisan bill moving through Congress would permanently establish a national AI research resource, reshaping...
Roku stock has slipped about 17% year-to-date, even as the company shows improving profitability and optimism for gro...
A rural Louisiana parish is undergoing a dramatic shift as Meta nears completion of a sprawling data center. The proj...
Strategy stock essentially leveraged means the company borrows to buy Bitcoin, making its fate closely tied to crypto...
Gordon Ritter argues that AI’s learning loop isn’t a job-killer countdown, but a shift toward human-driven innovation...
Lucid has dazzled with tech and range, but deep cash burn and production headwinds spark serious questions. Here’s a ...
A stock that falls 30% in 2026 isn’t automatically a loss. This guide shows how to evaluate a growth stock down 2026,...
The Fundrise VCX fund, once a magnet for IPO-obsessed investors, dropped 45% from its peak as market enthusiasm for p...
Bitcoin stalls near $77K as AI-focused Worldcoin jumps 25% in a single session, highlighting a split in crypto market...